Oracle preps upgrade to drug safety monitoring software

Following its January acquisition of software maker NetForce Inc., Oracle Corp. is preparing to release next month the first updated version of NetForce's flagship EventNet software for medical products manufacturers.

EventNet, now renamed the Oracle Adverse Event Reporting System (AERS), allows drug and medical-device manufacturers to track product problems and any adverse patient effects.

Oracle rebranded and began selling the application in February, but the forthcoming AERS 4.3 will be the first to be fully integrated with Oracle's software architecture, a change that lets users take advantage of Oracle's reporting and Web interface features, according to Keith Howells, vice president for pharmaceutical applications.

Oracle AERS works as a standalone product or as part of the Oracle Pharmaceutical Applications suite, where it shares information with the company's Oracle Clinical and Oracle Thesaurus Management data capture and management software. Pricing for the software is US$15,000 per user, according to Oracle's pricing guide.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about NetForceOracle

Show Comments